Heparin Protocol for Therapeutic Anticoagulation

Initial Dosing Regimen

The American College of Cardiology recommends an initial IV bolus of 80 units/kg followed by continuous infusion at 18 units/kg/hour, with aPTT monitoring at 6 hours and dose adjustments to maintain aPTT at 1.5-2.5 times control value 1
For continuous infusion, the dose is 18 units/kg/hour, which is approximately 20,000-40,000 units per 24 hours for an average adult, as recommended by the American Heart Association 2, 3

The American College of Chest Physicians recommends aPTT monitoring at 6 hours after initial bolus, with a target range of 1.5-2.5 times control value, which typically corresponds to 60-85 seconds depending on the reagent 2, 4, 1
Failure to achieve therapeutic aPTT within 24 hours increases the risk of recurrent thromboembolism 15-fold, according to the American Heart Association 2, 4

The following weight-based adjustments are recommended: for aPTT < 35 seconds, give 80 units/kg bolus and increase infusion by 4 units/kg/hour; for aPTT 35-45 seconds, give 40 units/kg bolus and increase infusion by 2 units/kg/hour; for aPTT 46-70 seconds, no change is needed; for aPTT 71-90 seconds, decrease infusion by 2 units/kg/hour; and for aPTT > 90 seconds, hold infusion for 1 hour and then decrease by 3 units/kg/hour, as recommended by the American College of Cardiology 1

In patients with severe renal failure (CrCl < 25-30 mL/min), unfractionated heparin is preferred over low-molecular-weight heparin due to hepatic metabolism, according to the European Society of Cardiology 6, 1
The American College of Cardiology recommends monitoring with anti-Xa activity if available in patients with severe renal failure 6

Different aPTT reagents have vastly different responsiveness to heparin, and the therapeutic range must be calibrated to the specific laboratory's reagent, according to the American Heart Association 2, 4, 1
Heparin clearance is dose-dependent and saturable at therapeutic doses, resulting in nonlinear pharmacokinetics, as reported by the American College of Cardiology 2, 7, 4
Heparin-induced thrombocytopenia is an absolute contraindication to continued heparin use, and alternative anticoagulants such as argatroban, danaparoid, or fondaparinux should be used instead, according to the American College of Chest Physicians 1

When heparin is used with glycoprotein IIb/IIIa inhibitors, the dose should be reduced by 50%, with an initial bolus of 50 units/kg, as recommended by the American Heart Association 8
The dose of heparin should be modified when combined with thrombolytics, according to the American College of Cardiology 2
Post-thrombolysis regimen: 5,000 unit bolus followed by 24,000 units per 24 hours, as recommended by the American Heart Association 3, 9